Form 4: Treace Medical Concepts Director, Jane E. Kiernan, Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Jane E. Kiernan reports acquisition of 23,917 shares and disposal of shares of Treace Medical Concepts, Inc. common stock on May 20, 2025.
Summary
- On May 20, 2025, Jane E. Kiernan, a director of Treace Medical Concepts, Inc. (TMCI), reported acquiring 23,917 shares of common stock.
- These shares were acquired as restricted stock units (RSUs), each convertible to one share of TMCI common stock upon vesting.
- The RSUs will fully vest by May 20, 2026, or the date of the 2026 annual meeting, contingent on continued service.
- Kiernan has deferred receipt of shares from RSU settlement until a change in control or separation of service.
- Kiernan also disposed of shares.
- Following these transactions, Kiernan beneficially owns 63,949 shares, including 24,861 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports transactions by an insider and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Future Outlook
The reporting person will receive shares of common stock upon vesting of the RSUs, with vesting contingent on continued service through May 20, 2026, or the date of the 2026 annual meeting of stockholders. The actual number of shares ultimately received will depend on continued service and any changes in control or separation of service.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard part of regulatory compliance for publicly traded companies. It provides transparency into the trading activities of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of transaction: Acquisition and disposal of common stock and RSUs. |
| 05/20/2026 | Date RSUs will be 100% vested, subject to continued service, or earlier at the 2026 annual meeting of stockholders. |
| 05/21/2025 | Date of Form 4 filing. |
Keywords
Treace Medical Concepts, TMCI, Form 4, Beneficial Ownership, Director, Jane E. Kiernan, Restricted Stock Units, RSUs, Stock Acquisition, Stock Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.